MedTrace Logo

Quantitative EEG During PSG in Patients With and Without Fibromyalgia

NCT01674179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2016-10-13

No results posted yet for this study

Summary

The purpose of this study is to retrospectively analyze Clinical and Nocturnal Polysomnographic Data (Overnight Sleep Studies) in patients with and without Fibromyalgia.

Fibromyalgia is a pain syndrome associated with dysfunctional sleep, fatigue, frequent awakenings, non-refreshing sleep, and alpha frequency intrusions. Quantitative EEG during routine Nocturnal Polysomnography can be used to assess Alpha/Delta sleep. Hypothesis: Alpha intrusions may be an objective marker for Fibromyalgia and may correlate with current clinical American College of Rheumatology Criteria for the diagnosis of Fibromyalgia.

Conditions

  • Fibromyalgia

Sponsors & Collaborators

  • SouthCoast Medical Group

    lead OTHER

Principal Investigators

  • Victor Rosenfeld, MD · SouthCoast Medical Group

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01674179 on ClinicalTrials.gov